Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 30Oropharyngeal Neoplasms 21Nasopharyngeal Carcinoma 15Head and Neck Neoplasms 13Prostatic Neoplasms 11Laryngeal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Carcinoma, Squamous Cell 8Carcinoma 8Breast Neoplasms 8Rectal Neoplasms 7Mouth Neoplasms 7Hypopharyngeal Neoplasms 7Glioma 6Glioblastoma 6Uterine Cervical Neoplasms 5Papillomavirus Infections 5Esophageal Neoplasms 5Urinary Bladder Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Nasopharyngeal Neoplasms 4Astrocytoma 4Mesothelioma, Malignant 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Endometrial Neoplasms 3Brain Neoplasms 3Tumor Virus Infections 2Tongue Neoplasms 2Thyroid Carcinoma, Anaplastic 2

Interventions

Paclitaxel 6pembrolizumab 3Cisplatin 3Carboplatin 3Biopsy 3adavosertib 2Trastuzumab 2Magnetic Resonance Spectroscopy 2Fulvestrant 2Doxorubicin 2ulixertinib 1tucatinib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1selinexor 1sapanisertib 1sacituzumab govitecan 1relugolix 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1niraparib 1larotrectinib 1ipatasertib 1erdafitinib 1dostarlimab 1dehydroftorafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Neoplasms × Radiotherapy, Intensity-Modulated × 1 year × Clear all
NCT06331468 2025-12-26

Hypofractionated Radiochemotherapy

University of Kentucky

Phase 2 Recruiting
20 enrolled
Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡